Skip to main content
Vaccine Hub offers general information only. Please see a healthcare professional for medical advice.
FAQ

What factors increase the risk of RSV?

Page last updated 10 December 2024

All children and adults are at risk of RSV. Up to 79% of children admitted to hospital with the infection are healthy and have no underlying medical conditions.10-12

    Despite everyone being at risk, there are some factors which may increase the likelihood of infection and developing severe illness from RSV:

    1. Age.

    • Babies aged under 12 months, especially those under 6 months, have underdeveloped immune systems and smaller, more fragile airways.13,14
    • Older adults are more susceptible to severe infection. This is because the immune system becomes less effective with age.4,13

    2. Underlying health conditions.

    • Children aged 2 years and under with conditions such as chronic lung disease or congenital heart disease are more at risk.1 
    • Older adults with conditions such as chronic heart or lung disease or weakened immune systems are more at risk.

    3. Pre-term delivery or low birth weight.

    • Children 2 years and under born pre-term or with a low birth weight have an increased risk of infection.1

    4. Month of birth.

    • Babies born before or at the start of the RSV season are exposed to RSV for the entire season, which may increase their risk of RSV infection.1

    Sources & Citations

    1. NSW Government. Respiratory syncytial virus (RSV). 2024. Available at: https://www.health.nsw.gov.au/Infectious/factsheets/Pages/respiratory-syncytial-virus.aspx (accessed November 2024).
    4. Lung Foundation Australia. Respiratory Syncytial Virus (RSV). 2024. Available at: https://lungfoundation.com.au/patients-carers/living-with-a-lung-disease/other-lung-conditions/respiratory-syncytial-virus-rsv/ (accessed November 2024). 
    10. Hall CB, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341–8.
    11. Arriola CS, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. J Pediatric Infect Dis Soc. 2020;9(5):587–95.
    12. Rha B, et al. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020;146(1):e20193611.
    13. Simon AK et al. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821):20143085.
    14. Di Cicco M et al. Structural and functional development in airways throughout childhood: Children are not small adults. Pediatr Pulmonol 2021;56(1):240–251.
    15. Mira‐Iglesias A, et al. Role of age and birth month in infants hospitalized with RSV-confirmed disease in the Valencia Region, Spain. Influenza Other Respir Viruses. 2022;16(2):328–39.

    MAT-AU-2402202-1.0 – 12/2024